Matritech (MZT-Amex) is a leading developer of proteomics-based diagnostic products for the early detection of cancer. Using its patented proteomics technology, Matritech has identified proteins correlated with bladder, cervical, breast, prostate and colon cancers.
(above from their website)
They have a FDA approved product for bladder cancer, but is barely hanging over a buck.(1.10 on Aug 13, 2004)
Matritech website:
matritech.com
Someday this stock might make money for some of us longs but more important I hope their products
work and save lives by early testing. |
